Publications by authors named "Erin Treemarcki"
Purpose: Pediatric rheumatologic diseases (PRDs) are characterized by high rates of anxiety and depression known to impact health-related outcomes. We present guidance statements to assess and manage mental health concerns for youth with PRDs in pediatric rheumatology practice.
Methods: Development of the guidance statements was initiated in 2019 and concluded in November 2023.
Article Synopsis
- The study examined the relationship between echocardiographic and laboratory findings at admission and the severity of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, focusing on vasoactive medication usage.
- Out of 118 patients, 48% were given vasoactive medication, with key indicators like elevated brain natriuretic peptide, C-reactive protein, and lower left ventricular ejection fraction linked to more severe disease.
- Results suggest that laboratory markers, particularly those indicating inflammation and heart injury, could be more effective in predicting MIS-C severity compared to strain parameters or LVEF, especially since many patients with a normal LVEF still required vasoactive support.
Objective: To assess the diagnostic and treatment practices among a variety of subspecialists at pediatric institutions in the US.
Study Design: Using a web-based survey, we assessed the consultation, diagnostic, and treatment preferences of providers from the different pediatric subspecialties who care for pediatric patients with hemophagocytic lymphohistiocytosis (HLH)/macrophage activating syndrome (MAS). Domains included demographics, provider training level and specialty, experience and comfort level with the diagnosis and treatment of HLH/MAS, and institutional approaches toward the diagnosis and management of HLH/MAS.
Objective: To validate the Juvenile Spondyloarthritis Disease Activity Index (JSpADA), and modified versions thereof, in a North American cohort of patients with enthesitis-related arthritis (ERA).
Methods: We utilized the Childhood Arthritis and Rheumatology Research Alliance Registry database ERA cohort to validate the JSpADA and its modifications (JSpADA6-no Schober, no C-reactive protein [CRP]/erythrocyte sedimentation rate [ESR]; JSpADA7-no Schober; and JSpADA7-no CRP/ESR) using the Outcome Measures in Rheumatology principles of face validity, discriminative validity, and responsiveness to change.
Results: There were 51 subjects (64 visits) with complete JSpADA data with a mean age of 13.
Mental Health in Pediatric Rheumatology: An Opportunity to Improve Outcomes.
Rheum Dis Clin North Am
February 2022
Mental health problems are more common in children with pediatric rheumatologic diseases (PRDs) than healthy peers. Mental health problems affect disease-related outcomes and health-related quality of life (HRQOL), so addressing these problems can improve clinical and psychosocial outcomes. Mental health screening tools are available, and there are resources available to aid in integrating mental health care into the clinical setting.
View Article and Find Full Text PDFObjective: Our objective was to develop and validate a composite disease flare definition for juvenile spondyloarthritis (SpA) that would closely approximate the clinical decision made to reinitiate or not reinitiate systemic therapy after therapy de-escalation.
Methods: Retrospective chart reviews of children with SpA who underwent systemic therapy de-escalation of biologic or conventional disease-modifying antirheumatic drugs were used to develop and validate the flare outcome. Data on independent cohorts for development (1 center) and validation (4 centers) were collected from large tertiary health care systems.
Purpose: To provide an overview of recent studies on pathogenesis, diagnosis, and management of juvenile spondyloarthritis (JSpA).
Recent Findings: Recent studies show differences in gut microbiome in patients with JSpA in comparison to healthy controls. There is increased recognition of the impact of the innate immune system on disease pathology.
Objective: Sjögren syndrome in children is a poorly understood autoimmune disease. We aimed to describe the clinical and diagnostic features of children diagnosed with Sjögren syndrome and explore how the 2016 ACR/EULAR classification criteria apply to this population.
Methods: An international workgroup retrospectively collected cases of Sjögren syndrome diagnosed under 18 years of age from 23 centres across eight nations.
Health-Related Quality of Life Measures in Childhood-Onset Systemic Lupus Erythematosus.
Arthritis Care Res (Hoboken)
October 2020
Objective: Mental health problems are prevalent in youth with rheumatologic disease. Gaps in knowledge exist regarding their effect, as well as strategies for detection and effective treatment. To address these gaps, the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Mental Health Workgroup developed and prioritized an agenda of research topics.
View Article and Find Full Text PDF